Journal of Skin and Stem Cell

Published by: Kowsar

PASH Syndrome: The First Case Report from Iran

Parvin Mansouri 1 , Zeinab Hesami 2 , Nima Hajiha 3 , Alireza Chalangari 4 , Katalin Martits Chalangari 4 and Zahra Azizian 2 , *
Authors Information
1 Skin and Stem Cell Research Center, Tehran University of Medical Sciences, Tehran, Iran
2 Iran University of Medical Sciences, Tehran, Iran
3 Tehran Medical Sciences Branch, Islamic Azad University, Tehran, Iran
4 Kassir Dermatology, Dallas, Texas
Article information
  • Journal of Skin and Stem Cell: December 31, 2018, 5 (4); e86096
  • Published Online: April 15, 2019
  • Article Type: Case Report
  • Received: November 5, 2018
  • Revised: February 1, 2019
  • Accepted: March 10, 2019
  • DOI: 10.5812/jssc.86096

To Cite: Mansouri P, Hesami Z, Hajiha N, Chalangari A , Chalangari K M, et al. PASH Syndrome: The First Case Report from Iran, J Skin Stem Cell. 2018 ; 5(4):e86096. doi: 10.5812/jssc.86096.

Copyright © 2019, Journal of Skin and Stem Cell. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Introduction
2. Case Presentation
3. Discussion
  • 1. Duchatelet S, Miskinyte S, Join-Lambert O, Ungeheuer MN, Frances C, Nassif A, et al. First nicastrin mutation in PASH (pyoderma gangrenosum, acne and suppurative hidradenitis) syndrome. Br J Dermatol. 2015;173(2):610-2. doi: 10.1111/bjd.13668. [PubMed: 25601011].
  • 2. Braun-Falco M, Kovnerystyy O, Lohse P, Ruzicka T. Pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH)--a new autoinflammatory syndrome distinct from PAPA syndrome. J Am Acad Dermatol. 2012;66(3):409-15. doi: 10.1016/j.jaad.2010.12.025. [PubMed: 21745697].
  • 3. Marzano AV, Ishak RS, Colombo A, Caroli F, Crosti C. Pyoderma gangrenosum, acne and suppurative hidradenitis syndrome following bowel bypass surgery. Dermatology. 2012;225(3):215-9. doi: 10.1159/000343602. [PubMed: 23171584].
  • 4. Scheinfeld N. Diseases associated with hidranitis suppurativa: Part 2 of a series on hidradenitis. Dermatol Online J. 2013;19(6):18558. [PubMed: 24011308].
  • 5. Dessinioti C, Katsambas A, Antoniou C. Hidradenitis suppurrativa (acne inversa) as a systemic disease. Clin Dermatol. 2014;32(3):397-408. doi: 10.1016/j.clindermatol.2013.11.006. [PubMed: 24767187].
  • 6. Gracia-Cazana T, Frias M, Rosello R, Vera-Alvarez J, Gilaberte Y. PASH syndrome associated with osteopoikilosis. Int J Dermatol. 2015;54(9):e369-71. doi: 10.1111/ijd.12827. [PubMed: 26175185].
  • 7. Marzano AV, Ceccherini I, Gattorno M, Fanoni D, Caroli F, Rusmini M, et al. Association of pyoderma gangrenosum, acne, and suppurative hidradenitis (PASH) shares genetic and cytokine profiles with other autoinflammatory diseases. Medicine (Baltimore). 2014;93(27). e187. doi: 10.1097/MD.0000000000000187. [PubMed: 25501066]. [PubMed Central: PMC4602806].
  • 8. Staub J, Pfannschmidt N, Strohal R, Braun-Falco M, Lohse P, Goerdt S, et al. Successful treatment of PASH syndrome with infliximab, cyclosporine and dapsone. J Eur Acad Dermatol Venereol. 2015;29(11):2243-7. doi: 10.1111/jdv.12765. [PubMed: 25352307].
  • 9. Join-Lambert O, Duchatelet S, Delage M, Miskinyte S, Coignard H, Lemarchand N, et al. Remission of refractory pyoderma gangrenosum, severe acne, and hidradenitis suppurativa (PASH) syndrome using targeted antibiotic therapy in 4 patients. J Am Acad Dermatol. 2015;73(5 Suppl 1):S66-9. doi: 10.1016/j.jaad.2015.07.040. [PubMed: 26470620].
  • 10. Gonul M, Cevirgen Cemil B, Keseroglu HO, Kaya Akis H. New described dermatological disorders. Biomed Res Int. 2014;2014:616973. doi: 10.1155/2014/616973. [PubMed: 25243162]. [PubMed Central: PMC4163364].
  • 11. Aksentijevich I, Kastner DL. Genetics of monogenic autoinflammatory diseases: past successes, future challenges. Nat Rev Rheumatol. 2011;7(8):469-78. doi: 10.1038/nrrheum.2011.94. [PubMed: 21727933].
  • 12. Naik HB, Cowen EW. Autoinflammatory pustular neutrophilic diseases. Dermatol Clin. 2013;31(3):405-25. doi: 10.1016/j.det.2013.04.001. [PubMed: 23827244]. [PubMed Central: PMC3703099].
  • 13. Mizutani Y, Okano T, Takahashi T, Ohnishi H, Ohara O, Sano A, et al. Pyoderma gangrenosum, acne and suppurative hidradenitis syndrome treated with granulocyte and monocyte adsorption apheresis. Acta Derm Venereol. 2017;97(2):275-6. doi: 10.2340/00015555-2507. [PubMed: 27384061].
  • 14. Calderon-Castrat X, Bancalari-Diaz D, Roman-Curto C, Romo-Melgar A, Amoros-Cerdan D, Alcaraz-Mas LA, et al. PSTPIP1 gene mutation in a pyoderma gangrenosum, acne and suppurative hidradenitis (PASH) syndrome. Br J Dermatol. 2016;175(1):194-8. doi: 10.1111/bjd.14383. [PubMed: 26713508].

Featured Image:

Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments